Intellectual Property

  • April 15, 2005

    Sharp, Sanyo Join DVD Patent Licensing Group

    Japanese electronics companies Sanyo Electric Co. and Sharp Corp. have joined a DVD patents licensing group that consists of some of the major DVD-related patent holders in the world, the group said Friday.

  • April 14, 2005

    Preliminary Injunction Casts Shadow Over Microsoft Release

    In a move that could spell trouble for the release of Microsoft’s next operating system, a small data-networking company has been granted a preliminary injunction in a patent infringement lawsuit against the software giant.

  • April 13, 2005

    South Korea Lifts Ban On Panasonic Plasma Displays In Patent Dispute

    South Korean authorities have ended an investigation into Japan's Matsushita Electric Industrial Co. and lifted a temporary ban on imports of the company's plasma display panels in the wake of the settlement of a patent dispute between Matsushita and Korea’s LG Electronics.

  • April 13, 2005

    In Trial Twist, Magma Co-Founder Backs Synopsys Claims

    In a stinging setback for Magma Design Automation, the company’s chief scientist and co-founder has admitted to using ideas he conceived of as an employee of Synopsys when he filed for two patents at the center of a dispute between the two rivals in the semiconductor industry.

  • April 13, 2005

    Celebrity Architect Awarded $5.9M In Copyright Case

    A California “architect to the stars” has won a copyright infringement lawsuit against a contractor who ripped off one of his designs to surreptitiously build a copycat mansion for himself in Beverly Hills, just a few miles away from the original building.

  • April 13, 2005

    Kos, Barr Settle Niaspan Patent Litigation With Unusual Deal

    Barr Pharmaceuticals Inc. and Kos Pharmaceuticals Inc. have penned an unusual settlement agreement to put an end to their patent litigation over Kos' cholesterol lowering drugs Niaspan and Advicor, the two companies said Wednesday.

  • April 13, 2005

    U.S. District Court To Issue Ruling In Zyprexa Case Thursday

    An Indiana judge will render his decision Thursday afternoon in Eli Lilly & Co.’s closely watched patent infringement lawsuit against would-be makers of generic versions of the company’s blockbuster schizophrenia treatment Zyprexa.

  • April 12, 2005

    Teco Countersues Sharp In LCD Patent Dispute

    Taiwan’s Teco Group has struck back against Japan’s Sharp Corp. in their dispute over patents for LCD television sets, suing the Japanese rival in Tokyo District Court for unfair competition.

  • April 11, 2005

    Barr Drops Suit Vs. FDA Over Allegra Marketing Exclusivity

    Generic drug maker Barr Pharmaceuticals Inc. has dropped a lawsuit against the U.S. Food and Drug Administration over exclusive marketing rights to a generic version of Sanofi-Aventis’ allergy treatment Allegra.

  • April 11, 2005

    Federal Circuit Rules For Tyco Unit In Patent Suit Vs. Masimo

    The U.S. Court of Appeals for the Federal Circuit has revived a lawsuit filed by Tyco International Ltd.'s Nellcor unit against Masimo Corp. over a patent for machines that measure the oxygen content in blood.

  • April 12, 2005

    Merck Sues Canadian Online Pharmacies Over Zocor Sales

    In an attempt to crack down on fast-growing cross-border sales of prescription drugs to U.S. consumers, drug maker Merck & Co. has filed a series of lawsuits against Canadian online pharmacies that ship Apotex’ generic version of Zocor south of the border.

  • April 11, 2005

    Shire Opts Not To Sue Teva Over Adderall XR ANDA

    Shire Pharmaceuticals Group has decided not to sue Israeli generics maker Teva Pharmaceuticals USA Inc. over its application for a generic version of the best-selling attention deficit drug Adderall XR.

  • April 11, 2005

    Federal Circuit Dismisses Apotex Suit V. Pfizer Over Accupril Patent

    The U.S. Court of Appeals for the Federal Circuit has dismissed Canadian generics maker Apotex Inc.’s lawsuit against Pfizer, Inc. after Pfizer covenanted not to sue Apotex for infringement of a patent for the hypertension drug Accupril.

  • April 8, 2005

    Movie Studios Lose Royalties After Missing Mailing Deadline

    Metro-Goldwyn-Mayer and Universal Studios will lose out on millions of dollars in royalties because their requests to the U.S. Copyright Office didn't carry valid U.S. Postal Service postmarks to prove they made a July 31 deadline, the U.S. Court of Appeals for the District of Columbia Circuit has ruled.

  • April 8, 2005

    Federal Circuit Rejects Peanut Butter And Jelly Sandwich Patents

    The U.S. Court of Appeals for the Federal Circuit has rejected J.M. Smucker Co.’s petitions for additional patents for a peanut butter and jelly sandwich.

  • April 8, 2005

    Glaxo Loses Paxil Suit At Federal Circuit

    In a blow to U.K. drug maker GlaxoSmithKline, the U.S. Court of Appeals for the Federal Circuit has ruled in favor of Canadian generics maker Apotex in a patent infringement lawsuit over the best-selling antidepressant Paxil.

  • April 8, 2005

    European Patent Office Upholds Monsanto's Roundup Patent

    In a decision that could have wide repercussions for farmers around the world, the European Patent Office has ruled that Monsanto Co. has the right to patent herbicide-resistant seeds in Europe.

  • April 8, 2005

    Acacia Targets Credit Card Fraud Protection In New Licensing Campaign

    A company that specializes in buying patent portfolios and enforcing them through aggressive litigation is now targeting a credit card fraud protection technology for a new licensing effort.

  • April 7, 2005

    Mosaid Slaps Infineon With Another Patent Suit Over Chip Technology

    Canadian chip maker Mosaid Technologies Inc. has filed another patent lawsuit against German rival Infineon Technologies AG in a Texas federal court, just days after facing a major setback in a separate lawsuit against the same company in New Jersey.

  • April 8, 2005

    Hasbro Loses Bid To Halt Monopoly Add-Ons

    A federal judge in New York has rejected toy maker Hasbro Inc.’s bid for a preliminary injunction against sales of a game that adds features to its Monopoly game.